CF
IMCR icon

Cantor Fitzgerald’s Immunocore IMCR Stock Holding History

Cantor Fitzgerald’s Portfolio IMCR Stock Details IMCR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$10.8M Buy
340,100
+89,889
+36% +$2.66M 0.12% 93
2026
Q1 		$7.54M Buy
+250,211
New +$8.09M 0.11% 88
2025
Q3 		– Sell
-25,001
Closed -$849K – 456
2025
Q2 		$785K Sell
25,001
-74,999
-75% -$2.33M 0.01% 179
2025
Q1 		$2.97M Buy
+100,000
New +$3M 0.06% 63
2024
Q4 		– Sell
-101,942
Closed -$3.17M – 308
2024
Q3 		$3.17M Sell
101,942
-152,085
-60% -$5.53M 0.09% 39
2024
Q2 		$8.61M Buy
+254,027
New +$13M 1.7% 14

Other funds holding IMCR

Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
RI
RTW Investments New York $11.7B AUM 174.13% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return
BG
Bellevue Group Kuesnacht, Switzerland $4.75B AUM 68.58% 1-Year Est. Return
TCM
Tang Capital Management San Diego, California $2.2B AUM 156.35% 1-Year Est. Return
VPC
Vestal Point Capital New York $4.28B AUM 239% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
AC
Armistice Capital New York $8.17B AUM 68.82% 1-Year Est. Return

Cantor Fitzgerald's IMCR Position: Q2 2026 in Review

Cantor Fitzgerald increased its Immunocore (IMCR) stake by 36% in Q2 2026, buying an estimated $2.66M and bringing the position to 340,100 shares worth $10.8M. The position accounts for 0.12% of the portfolio, ranked #93.

Cantor Fitzgerald first reported a position in IMCR in Q2 2024 and has held it in 6 quarters since. 136 funds tracked by Wall St. Rank hold IMCR as of Q2 2026.

  • Cantor Fitzgerald held 340,100 shares of Immunocore worth $10.8M as of Q2 2026.
  • Cantor Fitzgerald bought 89,889 Immunocore shares in Q2 2026, an estimated $2.66M.
  • Immunocore made up 0.12% of Cantor Fitzgerald's portfolio in Q2 2026, its #93 holding.
  • Cantor Fitzgerald first reported a position in Immunocore in Q2 2024 and has held it in 6 quarters since.
  • 136 funds tracked by Wall St. Rank held Immunocore as of Q2 2026.

Based on Cantor Fitzgerald's 13F filing for Q2 2026, filed 14 Aug 2026.